Cellebrite Reports Q3 Revenue of $126 Million and Net Income of $20.2 Million
Reuters
Nov 13
Cellebrite Reports Q3 Revenue of $126 Million and Net Income of $20.2 Million
Cellebrite DI Ltd. reported third-quarter 2025 results with annual recurring revenue $(ARR)$ up 19% to $439.8 million and revenue increasing 18% to $126.0 million. Net income reached $20.2 million, while non-GAAP net income was $36.9 million. Adjusted EBITDA was $37.7 million, representing a 29.9% adjusted EBITDA margin. For full-year 2025, Cellebrite expects ARR between $460 million and $475 million, reflecting 16% to 20% annual growth, and revenue between $470 million and $475 million, an annual growth of 17% to 18%. Adjusted EBITDA for the year is projected at $124 million to $127 million, with a margin of 26% to 27%. Recent business highlights include the Autumn 2025 Release, featuring advancements in the Digital Investigation Platform and the announcement of the upcoming Guardian Investigate solution, a SaaS-based investigative tool utilizing agentic AI, scheduled for general availability in early 2026. Subscription-based revenue grew by 21% during the period.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellebrite DI Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9574177-en) on November 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.